All posts

Descartes Systems still has 20 per cent upside, RBC says

Descartes Systems Group (Descartes Systems Group Stock Quote, Chart, News TSX:DSG)) just received a “Buy” rating and $67.00 per share target price from RBC Capital analyst Paul Treiber, who on Wednesday updated clients on the company.

Waterloo, Ontario-headquartered Descartes, an international logistics company with on-demand SaaS-based services for scheduling, tracking, invoicing and a full range of logistics processes, announced its fiscal second quarter 2021 financials on Wednesday, posting revenue up four per cent year-over-year to $84.0 million and adjusted EBITDA up 13 per cent year-over-year to $34.0 million. Those numbers were a shade lower than the previous quarter where revenue and EBITDA climbed seven and 15 per cent, respectively. (All figures in US dollars.)

On the results, CEO Edward J. Ryan said the past six months have cast a spotlight on the logistics industry as an essential service.

“Supply chain resilience and flexibility are now top-of-mind for governments and businesses alike,” said Ryan in a press release. “Technology and connectivity are central to navigating today’s dynamic landscape, helping to ensure the right goods and services are delivered to those that need them most. Our Global Logistics Network is well-positioned to help, by connecting shippers, carriers, logistics services providers and governments to efficiently and securely manage the lifecycle of shipments.”  

Descartes Q2 revenue was above Zacks consensus estimate by 2.7 per cent while EPS of $0.12 per share were in line with the consensus estimate.

Since hitting the bottom of the February and March market-wide pullback Descartes share price has been on a tear, climbing from $30 per share to as high as $63 earlier this month. For the year, DSGX is up 26 per cent.

At the time of publication, Treiber’s $67.00 target represented a projected 12-month return of 20.0 per cent.

Tagged with: dsg
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Ambarella wins price target raise at Roth

Roth Capital Markets analyst Suji Desilva raised his price target for Ambarella (Ambarella Stock Quote, Chart, News, Analysts, Financials NASDAQ:AMBA)… [Read More]

1 hour ago

Novo Nordisk is undervalued, this fund manager says

Darren Sissons, partner and portfolio manager at Campbell, Lee & Ross Investment Management, told BNN Bloomberg’s Market Call on Aug.… [Read More]

2 hours ago

The risk-to-return on NTG Clarity Networks is incredible, Beacon Securities says

Beacon Securities analyst Doug Cooper maintained a “Buy” rating and $5.00 target for NTG Clarity Networks (NTG Clarity Networks Stock… [Read More]

2 hours ago

NervGen Pharma price target chopped at Research Capital

Research Capital analyst Andre Uddin lowered his target price for NervGen Pharma (NervGen Pharma Stock Quote, Chart, News, Analysts, Financials… [Read More]

2 hours ago

Theralase Technologies is very undervalued, this analyst says

Research Capital analyst Andre Uddin maintained a “Speculative buy” rating and C$0.70 target price on Theralase Technologies (Theralase Technologies Stock… [Read More]

2 hours ago

Sabio Q2 gets thumbs up at Paradigm Capital

Paradigm Capital analyst Daniel Rosenberg reiterated a “Buy” rating and C$1.50 target price on Sabio Holdings (Sabio Holdings Stock Quote,… [Read More]

4 days ago